EGFR and glioblastoma: Intriguingly, WES data also revealed no typical molecular features of glioblastoma, IDH-wildtype (TERTp mutation, EGFR amplification, and 7 +/10−) in all tumor tissues, whereas all tumor tissues harbored TP53 mutation and PDGFRA amplification.